VanholderR, RingoirS.Bioincompatibility: an overview. Int J Artif Organs1989; 12: 356–65.
2.
CazenaveJP, MulvihillJ.Interactions of blood with surfaces: hemocompatibility and thromboresistance of biomaterials. Contributions to Nephrology1987; 62: 118–27.
ChuangHYK, SharptonTR, MohammedSF. Adsorption and reactivity of human fibrinogen and immunoglobulin G on two types of hemodialysis membranes. Int J Artif Organs1983; 6: 199–206.
5.
PackhamMA. The behavior of platelets at foreign surfaces. Proc Soc Exp Biol Med1988; 189: 261–74.
6.
HansonSR, HarkerLA. Vascular graft thrombus formation. Ann NY Acad Sci1987; 516: 653–61.
7.
BoschT, SchmidtB, BlumensteinM, GurlandHJ. Thrombogenicity markers in clinical and ex vivo assessment of membrane biocompatibility. Contr Nephrol1987; 59: 90–8.
8.
BarilinskiN, ShaykhM, DuneaG, Inhibiton of platelet function by uremic middle molecules. Nephron1985; 40: 423–8.
9.
KomarnickiM, PietrzakI.Mechanisms of platelet aggregation disturbances and their relation to treatment in patients with chronic uremia. Int J Artif Organs1988; 11: 91–4.
10.
VienerA, AviramM, BetterOS, BrookJG. Enhanced in vitro platelet aggregation in hemodialysis patients. Nephron1986; 43; 139–43.
11.
KnudsenF, DyerbergJ.Platelets and antithrombin III in uraemia: the acute effect of haemodialysis. Scand J Clin Lab Invest1985; 45: 341–7.
12.
AndrassyK, RitzE, BommerJ.Effects of hemodialysis on platelets. Contr Nephrol1987; 59: 26–34.
13.
SchmittGW, MoakeJL, RudyCK, VicksSL, HamburgerRJ. Alterations in hemostatic parameters during hemodialysis with dialyzers of different membrane composition and flow design. Am J Med1987; 83: 411–8.
14.
VaziriND, TooheyJT, PauleP, AlikhaniS, HungE.Effect of hemodialysis on contact group of coagulation factors, platelets, and leucocytes. Am J Med1984; 77: 437–41.
15.
SpeiserW, WojtaJ, KorningerC, Enhanced fibrinolysis caused by tissue plasminogen activator release in hemodialysis. Kidney Int1987; 32: 280–3.
16.
HakimRM, SchaferAI. Hemodialysis-associated platelet activation and thrombocytopenia. Am J Med1985; 78: 575–80.
17.
HildebrandU, QuellhorstE.Influence of various membranes on the coagulation system during dialysis. Contr Nephrol1985; 10: 46.
18.
WardRA, WellhausenSR, DobbinsJJ, JohnsonGS, DevriesWC. Thromboembolic and infectious complications of total artificial heart implantation. Ann NY Acad Sci1987; 516: 639–50.
19.
BurnsGL, OlsenDB. Thrombogenesis in and contiguous with pumping chambers. Ann NY Acad Sci1987; 516: 662–72.
20.
NiewiarowskiD, HuangF, RucinskiB, Potential application of RGD containing peptides from viper venoms (disintegrins) in antiplatelet therapy. Thrombosis and Haemostasis1989; 62: 319.
21.
SchraderJ, StibbeW, ArmstrongVW, Comparison of low molecular weight heparins to standard heparin in hemodialysis/hemofiltation. Kidney Int1988; 33: 890–6.
22.
SmithMC, DanviriyasupK, CrowJW, Prostacyclin substitution for heparin in long-term hemodialysis. Am J Med1982; 73: 669–78.
23.
LohrJW, SlusherS, DiederichD.Safety of regional citrate hemodialysis in acute renal failure. Am J Kidney Dis1989; 13: 104–7.
24.
CaruanaRJ, RajaRM, BushJV, KramerMS, GoldsteinSJ. Heparin free dialysis: comparative data and results in high risk patients. Kidney Int1987: 31: 1351–5.
25.
MaedaK, UsudaM, KawaguchiS, Effects of Ticlopidine on thrombotic obstruction of A-V shunts and on dialysance of artificial kidneys. Artif Organs1980; 4: 30–3.
26.
GrontoftKCH, MulecH, GutierrezA, OlanderR.Thromboprophylactic effect of Ticlopidine in arteriovenous fistulas for haemodialysis. Scand J Urol Nephrol1985; 19: 55–7.
